ReviewCureus2026
Visual Outcomes and Complication Profiles of Phacoemulsification in Diabetic Versus Non-diabetic Patients.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic patients undergoing phacoemulsification for cataracts face an elevated risk of intraoperative and postoperative complications due to systemic and ocular pathophysiological changes. This narrative review aims to systematically compare visual outcomes and complication profiles between diabetic and non-diabetic individuals following phacoemulsification, while identifying current best practices and future research directions. With rising global diabetes prevalence, cataract surgery in diabetic patients is increasingly common. Understanding the interaction between diabetes-related ocular changes and phacoemulsification outcomes is vital for improving surgical planning, reducing complications, and enhancing patient satisfaction. A comprehensive literature search was conducted across PubMed, Scopus, and Web of Science using Medical Subject Headings (MeSH) and free-text terms. Eligible studies from 2020 to 2025 were selected based on predefined criteria. Data were narratively synthesized across themes, including intraoperative challenges, visual acuity outcomes, macular health, adjunctive therapies, and long-term prognosis. Diabetic patients exhibit higher risks of poor pupil dilation, capsular fragility, macular edema, and slower visual recovery. However, with good glycemic control, preoperative retinal evaluation, and adjunctive therapies, outcomes can closely approximate those of non-diabetics. Tailored perioperative management and interdisciplinary care models are critical for optimizing outcomes in diabetic cataract surgery. Future studies should focus on stratified risk assessment and long-term visual prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.